Fig. 2

Risk score based on the 4-mRNA signature predicts OS in patients with bladder cancer. a The distribution of the 4-mRNA risk score and survival status for each patient. b Kaplan–Meier curve of OS in high- and low-risk groups. c Time-dependent ROC curves of the 4-mRNA signature for prediction of 3- and 5-year OS. d Univariable and multivariable analyses for the risk score and each clinical feature